Prof. Georg Hansmann Friedrich Alexander University (FAU) Erlangen, Germany

Prof. Dr. Georg Hansmann, MD, PhD, MBA is an attending pediatric and adult congenital cardiologist and Professor at Friedrich-Alexander-Universität Erlangen-Nürnberg in Erlangen, Germany. He became Visiting Professor at Harvard Medical School in May 2025.... read more

Prof. Hansmann served as the founding chair of the AEPC Working Group on "Pulmonary Hypertension, Heart Failure and Transplantation" from 2015 to 2018 and as a councilor from 2018 to 2021. Additionally, he is the founding and current chair of the European Pediatric Pulmonary Vascular Disease Network (EPPVDN, 2015–present; www.pvdnetwork.org).

Prof. Hansmann co-chaired the 2015 AHA/ATS Guidelines on Pediatric Pulmonary Hypertension and chaired the 2019 EPPVDN Consensus Statement on Pediatric Pulmonary Hypertension, as well as several upcoming consensus statements (2026) which will be endorsed by major medical societies. Georg Hansmann contributed as a task force member to the 2015 ESC/ERS Guidelines on Pulmonary Hypertension, the 2022 ISHLT Consensus Statement on the peri-operative management of PH and right heart failure, and the 2025 AHA Consensus Statement on the clinical management and transplant considerations in pediatric pulmonary hypertension due to left heart failure.

As a federally funded principal investigator in cardiovascular biomedicine, Prof. Hansmann has authored original research articles published in Cell, Science, and Nature, as well as in leading cardiovascular journals such as Circulation, Circulation Research, Journal of Clinical Investigation, and The Journal of Heart and Lung Transplantation (h-index 50; > 21,000 citations). He also serves as the clinical cardiologist and principal investigator for the Pediatric Long-COVID Kids Study at Hannover Medical School, Germany.

Prof. Hansmann’s trainees have received prestigious international awards and research grants (including from NIH, FEBS, AEPC, and EU/ERS), have published in high-impact journals (impact factor >10), and have been recruited by leading universities in the United States and the United Kingdom.